>
"SPIRITS TOLD US" – Chief Says NO PROOF NEEDED For 215 KAMLOOPS GRAVES!!
Financial Repression: How the US Government Will Quietly Confiscate Your Wealth
U.S. Troops' Death Means "All Out War" with Iran!
One of the Greatest Betrayals of Public Trust in American History
Anthropic is launching its own drug discovery programs for rare diseases using Claude...
SpaceX AI Satellites Will Have 250 Kilowatts of Power
Chinese researchers have developed a sodium-metal battery that can fully charge in just 4 minutes...
SpaceX Starship Flight 13 in 3 Days - Thursday July 13
Chinese Scientists Develop Nuclear Battery Using Carbon-14
Teleoperated humanoid robots complete first-ever live surgery
Floating capsule auto-disinfects water without chemicals or battery
Modular Reactors To Solve Data Center Hysteria?
DeepSeek Developing In-House AI Chip In Bid To Cut Nvidia Reliance
America just took three brand-new nuclear reactors critical in thirty days, a first for any...

Over the past year, the gap between the super-rich and the rest of us has grown wider than ever before.
But the difference between ordinary people and billionaires might be more than just money. Some high net worth individuals have been looking into extending their lives far beyond the 70 or 80 years most of us might hope for.
Peter Thiel, for example, the billionaire co-founder of PayPal, has invested in a number medical research start-ups looking extending life expectancy though his Breakout Labs fund.
One of the companies longevity obsessive Thiel has bankrolled is Ambrosia.
Ambrosia is one of three outfits looking at experimental "vampire" blood transfusions that put the blood of young people into the lens of oldies.
According to commercial finance experts ABC Finance, the cost of the trials currently ranges from £6,000 to about £215,000.